Location History:
- Maidenhead, GB (1988)
- Ruscombe, GB (2001 - 2006)
- Berkshire, GB (2017)
Company Filing History:
Years Active: 1988-2017
Title: The Innovative Contributions of Edward Stewart Johnson
Introduction
Edward Stewart Johnson is a notable inventor based in Ruscombe, Great Britain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at improving drug absorption and efficacy. With a total of six patents to his name, Johnson's work has the potential to impact the treatment of various medical conditions.
Latest Patents
One of Johnson's latest patents is a pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase B inhibitors. This invention provides a fast-dispersing oral solid dosage form containing a monoamine oxidase B inhibitor, such as selegiline, as the active ingredient. The composition is designed to promote absorption through the buccal, sublingual, pharyngeal, and/or esophageal mucous membrane tissue, ensuring that at least 5% of the active ingredient is absorbed within one minute of placement in the oral cavity. This innovation addresses the challenges associated with the first-pass effect and offers advantages for patients who have difficulty swallowing.
Another significant patent by Johnson involves an opioid agonist in a fast-dispersing dosage form. This invention relates to a pharmaceutical composition for oral administration that includes a carrier and an opioid (μ receptor) agonist, such as fentanyl. The composition is designed to release the active ingredient rapidly in the oral cavity, making it suitable for various medical applications, including pain management and anesthesia.
Career Highlights
Throughout his career, Johnson has worked with reputable companies, including R.P. Scherer Technologies, Inc. and R.P. Scherer Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and drug formulation.
Collaborations
Johnson has collaborated with notable colleagues, including Anthony Clarke and Jon Lacy. These partnerships have likely enriched his work and expanded the scope of his inventions.
Conclusion
Edward Stewart Johnson's contributions to pharmaceutical innovations demonstrate his commitment to improving patient care through effective drug delivery systems. His patents reflect a deep understanding of the challenges in medication administration and offer promising solutions for various medical conditions.